Related Experiment Video
Updated: May 18, 2026

Detection of DNA Double-Stranded Breaks in Mouse Oocytes
Published on: June 23, 2023
Doxorubicin induces early embryo apoptosis by inhibiting poly(ADP ribose) polymerase
Qing-Ling Wang1, Shao-Chen Sun, Jemesbond Han
1Department of Animal Sciences, Chungbuk National University, Chungbuk, Cheongju 361-763, South Korea.
Background:
The effect of Doxorubicin, a widely used chemotherapeutic agent, on early mouse embryonic development has not been previously characterized.
Materials And Methods:
Expression of apoptosis-related genes and poly(ADP-ribose) polymerase (PARP) family genes were assessed by real-time reverse transcription polymerase chain reaction (RT-PCR). Apoptosis in mouse blastocysts was tested using the terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay. Cleaved (c)-PARP was analyzed by western blot.
Results:
A 20 h exposure to doxorubicin caused rapid cytoplasmic fragmentation, DNA condensation and disruption of the cytoskeleton in mouse embryos. Doxorubicin altered the expression of genes involved in DNA repair and apoptosis and blocked early embryonic development, suggesting that doxorubicin affects DNA synthesis and repair. Furthermore, the effect of doxorubicin on early embryo development was determined by assessing the rates of development to different stages and an apoptosis index. Both assays confirmed that doxorubicin altered embryonic development. In conclusion, doxorubicin blocked pre-implantation development in early mouse embryos by altering apoptosis-related gene expression and inactivating DNA repair by PARP.
Insights
Doxorubicin exposure halts early mouse embryo development by disrupting DNA repair and increasing apoptosis. This chemotherapy agent impacts pre-implantation development, affecting gene expression and cellular integrity.
Area of Science:
- Reproductive Biology
- Developmental Biology
- Toxicology
Background:
- Doxorubicin is a common chemotherapy drug.
- Its impact on early mouse embryonic development is unknown.
Purpose of the Study:
- To investigate the effects of doxorubicin on early mouse embryonic development.
- To characterize doxorubicin's impact on gene expression related to apoptosis and DNA repair.
Main Methods:
- Real-time RT-PCR to assess apoptosis and PARP gene expression.
- TUNEL assay to detect apoptosis in blastocysts.
- Western blot to analyze cleaved PARP (c-PARP).
Main Results:
- Doxorubicin exposure caused cytoplasmic fragmentation, DNA condensation, and cytoskeletal disruption.
- Altered expression of DNA repair and apoptosis genes observed.
- Blocked pre-implantation embryonic development and increased apoptosis index.
Conclusions:
- Doxorubicin inhibits early mouse embryonic development.
- It disrupts apoptosis-related gene expression and inactivates DNA repair via PARP.
- Affects DNA synthesis and repair, leading to developmental arrest.
Related Concept Videos
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
The Intrinsic Apoptotic Pathway
Nondisjunction
Negative Regulator Molecules
